glp 1 agonists vs sglt2 inhibitors SGLT-2 and GLP-1 Agonists: First-Line Therapy for Diabetes With Established Cardiovascular Disease GLP1 Receptor Agonists vs SGLT2-I

Given that different GLP-1 receptor agonists have different dosing recommendations (Table 1), it is important that patients switching between such agents are counseled on any applicable changes to their previous regimen

While GLP-1-related hair loss can occur, it typically results from rapid weight loss and nutritional deficiencies rather than direct medication effects

Panagaki T, Michael M, Hlscher C

(A weight-related condition is a health problem linked to excess weight, such as high blood pressure, high cholesterol, type 2 diabetes, prediabetes, fatty liver disease, or sleep apnea.) Semaglutide (Ozempic, Wegovy, Rybelsus) Ozempic and Rybelsus are approved for type 2 diabetes

Over the next year, the placebo group regained 14% of their weight, while the Zepbound group lost an additional 5.5%

CAROLYN BRAMANTE: Yeah, so exactly, that's one of the concerns, especially in older adults, is that weight loss usually goes with losing muscle and fat-- fat tissue